Patent expiration pressures revenue as FMC pursues $1 billion debt reduction through asset sales.

Investors need to pay close attention to DAKT stock based on the movements in the options market lately.

Evaluate FMC's (FMC) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.

FMC stock is back in focus because the share price has fallen sharply over the past few years, yet the valuation checks still lean cheap. After years of weak returns, the question for investors is whether the current market price already reflects most of the bad news. Over the past 5 years, FMC has delivered a return decline of about 86.8%, which signals a major reset in market expectations for the company. Recent business moves, including asset sales and new investment, can support balance...

FMC (FMC) shares are in focus after the agricultural sciences company reported a second quarter net loss of US$186.6 million on sales of US$867.1 million, alongside reduced full year 2026 revenue guidance. See our latest analysis for FMC. FMC shares have come under pressure, with the latest 1 day share price return down 9.47% and the year to date share price return down 25.31%. The 1 year total shareholder return has fallen 70.82%, indicating that sentiment around recent earnings, reduced...

While the top- and bottom-line numbers for FMC (FMC) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

FMC (NYSE:FMC) reported second-quarter revenue of $841 million excluding India, below the low end of its guidance range, as cautious customer purchasing, unfavorable weather, low insect pressure and pricing pressure weighed on demand. However, adjusted EBITDA of $153 million exceeded the high end of

Despite lowering full-year guidance due to pricing pressure and weak demand, FMC Corp (FMC) beat Q2 EBITDA expectations and is positioning for a return to growth in 2027.

The beaten-down fertilizer stock reported some disappointing earnings, but also de-risked its story by paying down debt.

FMC's Q2 earnings beat estimates as cost gains offset weaker pricing and volumes. Revenues declined and 2026 sales guidance was cut.

Moby summary of FMC Corporation's Q2 2026 earnings call

FMC (FMC) delivered earnings and revenue surprises of +23.81% and -7.03%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Corteva's earnings beat, rising estimates and innovation pipeline support momentum, but premium valuation and separation costs raise execution risk.

CTVA's Seed pricing, Crop Protection volumes and cost savings support growth ahead of its planned fourth-quarter 2026 separation.

Corteva, Inc. (CTVA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

FMC (FMC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

FMC stock is trading near the lowest level in over two decades as the company continues to battle several challenges. It, however, can be a speculative buy for aggressive investors given the low valuations.